Corneal biomechanical changes after crosslinking for progressive keratoconus with the corneal visualization scheimpflug technology

Standard

Corneal biomechanical changes after crosslinking for progressive keratoconus with the corneal visualization scheimpflug technology. / Steinberg, Johannes; Katz, Toam; Mousli, Aiham; Frings, Andreas; Casagrande, Maria K; Druchkiv, Vasyl; Richard, Gisbert; Linke, Stephan J.

In: BMC OPHTHALMOL, Vol. 2014, 01.01.2014, p. 579190.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{5f920fa696b64af4b2694636e3a00a25,
title = "Corneal biomechanical changes after crosslinking for progressive keratoconus with the corneal visualization scheimpflug technology",
abstract = "Purpose. To evaluate the effect of corneal crosslinking in progressive keratoconus by applying in vivo corneal visualization Scheimpflug technology. Design. Longitudinal retrospective study. Subjects and Controls. Seventeen eyes of patients treated with corneal crosslinking for progressive keratoconus. Methods. Corneal visualization Scheimpflug technology analyses (research software version 6.07r08) of subjects with progressive keratoconus before and 3 months after corneal crosslinking (CXL) were reviewed retrospectively. t-test (for normal distribution) and Wilcoxon matched-pairs test (if not normally distributed) were used to test for statistically significant differences between pre- and post-CXL analyses. Results. We demonstrated statistically significant differences for the intraocular pressure (median: +3 mmHg, P = 0.004), the central corneal pachymetry (pachy; mean: -35 µm, P < 0.001), the timespan between the air impulse release and the first applanation of the cornea (A1time; median: +0.12 ms, P < 0.05), and the timespan between the air impulse release and the second applanation of the cornea (A2time; median: -37 ms, P < 0.05). Conclusions. With the A1time and the A2time, we identified two parameters that demonstrated a statistically significant improvement of the biomechanical properties of the cornea after CXL. Despite the known initial decrease of the pachymetry after CXL, none of the analyzed parameters indicated a progression of the keratoconus.",
author = "Johannes Steinberg and Toam Katz and Aiham Mousli and Andreas Frings and Casagrande, {Maria K} and Vasyl Druchkiv and Gisbert Richard and Linke, {Stephan J}",
year = "2014",
month = jan,
day = "1",
doi = "10.1155/2014/579190",
language = "English",
volume = "2014",
pages = "579190",
journal = "BMC OPHTHALMOL",
issn = "1471-2415",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Corneal biomechanical changes after crosslinking for progressive keratoconus with the corneal visualization scheimpflug technology

AU - Steinberg, Johannes

AU - Katz, Toam

AU - Mousli, Aiham

AU - Frings, Andreas

AU - Casagrande, Maria K

AU - Druchkiv, Vasyl

AU - Richard, Gisbert

AU - Linke, Stephan J

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose. To evaluate the effect of corneal crosslinking in progressive keratoconus by applying in vivo corneal visualization Scheimpflug technology. Design. Longitudinal retrospective study. Subjects and Controls. Seventeen eyes of patients treated with corneal crosslinking for progressive keratoconus. Methods. Corneal visualization Scheimpflug technology analyses (research software version 6.07r08) of subjects with progressive keratoconus before and 3 months after corneal crosslinking (CXL) were reviewed retrospectively. t-test (for normal distribution) and Wilcoxon matched-pairs test (if not normally distributed) were used to test for statistically significant differences between pre- and post-CXL analyses. Results. We demonstrated statistically significant differences for the intraocular pressure (median: +3 mmHg, P = 0.004), the central corneal pachymetry (pachy; mean: -35 µm, P < 0.001), the timespan between the air impulse release and the first applanation of the cornea (A1time; median: +0.12 ms, P < 0.05), and the timespan between the air impulse release and the second applanation of the cornea (A2time; median: -37 ms, P < 0.05). Conclusions. With the A1time and the A2time, we identified two parameters that demonstrated a statistically significant improvement of the biomechanical properties of the cornea after CXL. Despite the known initial decrease of the pachymetry after CXL, none of the analyzed parameters indicated a progression of the keratoconus.

AB - Purpose. To evaluate the effect of corneal crosslinking in progressive keratoconus by applying in vivo corneal visualization Scheimpflug technology. Design. Longitudinal retrospective study. Subjects and Controls. Seventeen eyes of patients treated with corneal crosslinking for progressive keratoconus. Methods. Corneal visualization Scheimpflug technology analyses (research software version 6.07r08) of subjects with progressive keratoconus before and 3 months after corneal crosslinking (CXL) were reviewed retrospectively. t-test (for normal distribution) and Wilcoxon matched-pairs test (if not normally distributed) were used to test for statistically significant differences between pre- and post-CXL analyses. Results. We demonstrated statistically significant differences for the intraocular pressure (median: +3 mmHg, P = 0.004), the central corneal pachymetry (pachy; mean: -35 µm, P < 0.001), the timespan between the air impulse release and the first applanation of the cornea (A1time; median: +0.12 ms, P < 0.05), and the timespan between the air impulse release and the second applanation of the cornea (A2time; median: -37 ms, P < 0.05). Conclusions. With the A1time and the A2time, we identified two parameters that demonstrated a statistically significant improvement of the biomechanical properties of the cornea after CXL. Despite the known initial decrease of the pachymetry after CXL, none of the analyzed parameters indicated a progression of the keratoconus.

U2 - 10.1155/2014/579190

DO - 10.1155/2014/579190

M3 - SCORING: Journal article

C2 - 25332832

VL - 2014

SP - 579190

JO - BMC OPHTHALMOL

JF - BMC OPHTHALMOL

SN - 1471-2415

ER -